A detailed history of Black Rock Inc. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,622,618 shares of ARQT stock, worth $73.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,622,618
Previous 6,658,741 29.49%
Holding current value
$73.5 Million
Previous $66 Million 21.52%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.24 - $12.53 $14.2 Million - $24.6 Million
1,963,877 Added 29.49%
8,622,618 $80.2 Million
Q1 2024

May 10, 2024

BUY
$3.25 - $11.77 $2.41 Million - $8.74 Million
742,195 Added 12.54%
6,658,741 $66 Million
Q4 2023

Feb 13, 2024

BUY
$1.84 - $4.82 $3.49 Million - $9.14 Million
1,896,145 Added 47.16%
5,916,546 $19.1 Million
Q3 2023

Nov 13, 2023

SELL
$5.31 - $10.98 $1.12 Million - $2.32 Million
-210,973 Reduced 4.99%
4,020,401 $21.3 Million
Q2 2023

Aug 11, 2023

SELL
$7.51 - $15.0 $2.76 Million - $5.5 Million
-366,898 Reduced 7.98%
4,231,374 $40.3 Million
Q1 2023

May 12, 2023

SELL
$10.23 - $17.14 $6.3 Million - $10.6 Million
-615,986 Reduced 11.81%
4,598,272 $50.6 Million
Q4 2022

Feb 13, 2023

BUY
$13.96 - $20.4 $1.85 Million - $2.7 Million
132,514 Added 2.61%
5,214,258 $77.2 Million
Q3 2022

Nov 14, 2022

BUY
$17.85 - $26.95 $8.99 Million - $13.6 Million
503,591 Added 11.0%
5,081,744 $97.1 Million
Q2 2022

Aug 12, 2022

BUY
$16.33 - $22.2 $4.28 Million - $5.82 Million
262,351 Added 6.08%
4,578,153 $97.6 Million
Q1 2022

May 12, 2022

BUY
$14.38 - $22.79 $27,868 - $44,167
1,938 Added 0.04%
4,315,802 $83.1 Million
Q4 2021

Feb 10, 2022

BUY
$14.98 - $25.5 $1.77 Million - $3.01 Million
117,938 Added 2.81%
4,313,864 $89.5 Million
Q3 2021

Nov 09, 2021

SELL
$19.28 - $27.1 $1.02 Million - $1.43 Million
-52,694 Reduced 1.24%
4,195,926 $100 Million
Q2 2021

Aug 11, 2021

BUY
$24.42 - $34.75 $104 Million - $148 Million
4,248,620 New
4,248,620 $116 Million

Others Institutions Holding ARQT

About Arcutis Biotherapeutics, Inc.


  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $513M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.